Grant Funding Opportunity for Rare Diseases Research – Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) is pleased to announce availability of funds to support clinical trials for rare diseases and conditions. The purpose of this funding opportunity announcement is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in…
